The US health regulator has provided its tentative approval to Alembic Pharmaceuticals for Febuxostat tablets that are used in the treatment of hyperuricemia in patients...
Alembic Pharma has got the USFDA’s final approval for Lacosamide tablets which are used for the treatment of partial-onset seizures in the American market. Alembic...